Brief: Opsens receives FDA 510(k) clearance for OptoWire II
16/03/2016 12:00
March 16 (Reuters) - Opsens Inc OPS.V
* Opsens deploying its FFR products in U.S. Market
* Opsens receives FDA 510(k) clearance for the OptoWire II
Source text for Eikon: ID:nCNWQTkvha
Further company coverage: OPS.V
((Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe